Two Sigma Advisers’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.31M | Buy |
|
|||||
|
2025
Q1 | $847K | Buy |
|
|||||
|
2024
Q4 | $259K | Sell |
|
|||||
|
2024
Q3 | $636K | Sell |
|
|||||
|
2024
Q2 | $958K | Sell |
|
|||||
|
2024
Q1 | $1.47M | Buy |
|
|||||
|
2023
Q4 | $497K | Sell |
|
|||||
|
2023
Q3 | $629K | Sell |
|
|||||
|
2023
Q2 | $697K | Sell |
|
|||||
|
2023
Q1 | $1.11M | Buy |
|
|||||
|
2022
Q4 | $556K | Buy |
|
|||||
|
2022
Q3 | $239K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $57K | Sell |
|
|||||
|
2021
Q4 | $304K | Sell |
|
|||||
|
2021
Q3 | $379K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $171K | Buy |
|
|||||
|
2020
Q4 | $210K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $173K | Sell |
|
|||||
|
2020
Q1 | $165K | Sell |
|
|||||
|
2019
Q4 | $265K | Hold |
|
|||||
|
2019
Q3 | $176K | Buy |
|
|||||
|
2019
Q2 | $215K | Buy |
|
|||||
|
2019
Q1 | $231K | Buy |
|
|||||
|
2018
Q4 | $152K | Buy |
|
|||||
|
2018
Q3 | $167K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $218K | Buy |
|